2025-07-032026-07-312026-07-31false16558472NOMAD NEUROSCIENCE LTD2026-10-0171129falseiso4217:GBPxbrli:pure165584722025-07-02165584722026-07-31165584722025-07-032026-07-31165584722025-07-01165584722025-07-02165584722025-07-022025-07-0216558472bus:SmallEntities2025-07-032026-07-3116558472bus:AuditExempt-NoAccountantsReport2025-07-032026-07-3116558472bus:FullAccounts2025-07-032026-07-3116558472bus:PrivateLimitedCompanyLtd2025-07-032026-07-3116558472core:WithinOneYear2026-07-3116558472core:AfterOneYear2026-07-3116558472core:WithinOneYear2025-07-0216558472core:AfterOneYear2025-07-0216558472core:ShareCapital2026-07-3116558472core:SharePremium2026-07-3116558472core:RevaluationReserve2026-07-3116558472core:OtherReservesSubtotal2026-07-3116558472core:RetainedEarningsAccumulatedLosses2026-07-3116558472core:ShareCapital2025-07-0216558472core:SharePremium2025-07-0216558472core:RevaluationReserve2025-07-0216558472core:OtherReservesSubtotal2025-07-0216558472core:RetainedEarningsAccumulatedLosses2025-07-0216558472core:LandBuildings2026-07-3116558472core:PlantMachinery2026-07-3116558472core:Vehicles2026-07-3116558472core:FurnitureFittings2026-07-3116558472core:OfficeEquipment2026-07-3116558472core:NetGoodwill2026-07-3116558472core:IntangibleAssetsOtherThanGoodwill2026-07-3116558472core:ListedExchangeTraded2026-07-3116558472core:UnlistedNon-exchangeTraded2026-07-3116558472core:LandBuildings2025-07-0216558472core:PlantMachinery2025-07-0216558472core:Vehicles2025-07-0216558472core:FurnitureFittings2025-07-0216558472core:OfficeEquipment2025-07-0216558472core:NetGoodwill2025-07-0216558472core:IntangibleAssetsOtherThanGoodwill2025-07-0216558472core:ListedExchangeTraded2025-07-0216558472core:UnlistedNon-exchangeTraded2025-07-0216558472core:LandBuildings2025-07-032026-07-3116558472core:PlantMachinery2025-07-032026-07-3116558472core:Vehicles2025-07-032026-07-3116558472core:FurnitureFittings2025-07-032026-07-3116558472core:OfficeEquipment2025-07-032026-07-3116558472core:NetGoodwill2025-07-032026-07-3116558472core:IntangibleAssetsOtherThanGoodwill2025-07-032026-07-3116558472core:ListedExchangeTraded2025-07-032026-07-3116558472core:UnlistedNon-exchangeTraded2025-07-032026-07-3116558472core:MoreThanFiveYears2025-07-032026-07-3116558472core:Non-currentFinancialInstruments2026-07-3116558472core:Non-currentFinancialInstruments2025-07-0216558472dpl:CostSales2025-07-032026-07-3116558472dpl:DistributionCosts2025-07-032026-07-3116558472core:LandBuildings2025-07-032026-07-3116558472core:PlantMachinery2025-07-032026-07-3116558472core:Vehicles2025-07-032026-07-3116558472core:FurnitureFittings2025-07-032026-07-3116558472core:OfficeEquipment2025-07-032026-07-3116558472dpl:AdministrativeExpenses2025-07-032026-07-3116558472core:NetGoodwill2025-07-032026-07-3116558472core:IntangibleAssetsOtherThanGoodwill2025-07-032026-07-3116558472dpl:GroupUndertakings2025-07-032026-07-3116558472dpl:ParticipatingInterests2025-07-032026-07-3116558472dpl:GroupUndertakingscore:ListedExchangeTraded2025-07-032026-07-3116558472core:ListedExchangeTraded2025-07-032026-07-3116558472dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-07-032026-07-3116558472core:UnlistedNon-exchangeTraded2025-07-032026-07-3116558472dpl:CostSales2025-07-022025-07-0216558472dpl:DistributionCosts2025-07-022025-07-0216558472core:LandBuildings2025-07-022025-07-0216558472core:PlantMachinery2025-07-022025-07-0216558472core:Vehicles2025-07-022025-07-0216558472core:FurnitureFittings2025-07-022025-07-0216558472core:OfficeEquipment2025-07-022025-07-0216558472dpl:AdministrativeExpenses2025-07-022025-07-0216558472core:NetGoodwill2025-07-022025-07-0216558472core:IntangibleAssetsOtherThanGoodwill2025-07-022025-07-0216558472dpl:GroupUndertakings2025-07-022025-07-0216558472dpl:ParticipatingInterests2025-07-022025-07-0216558472dpl:GroupUndertakingscore:ListedExchangeTraded2025-07-022025-07-0216558472core:ListedExchangeTraded2025-07-022025-07-0216558472dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-07-022025-07-0216558472core:UnlistedNon-exchangeTraded2025-07-022025-07-0216558472core:NetGoodwill2026-07-3116558472core:IntangibleAssetsOtherThanGoodwill2026-07-3116558472core:LandBuildings2026-07-3116558472core:PlantMachinery2026-07-3116558472core:Vehicles2026-07-3116558472core:FurnitureFittings2026-07-3116558472core:OfficeEquipment2026-07-3116558472core:AfterOneYear2026-07-3116558472core:WithinOneYear2026-07-3116558472core:ListedExchangeTraded2026-07-3116558472core:UnlistedNon-exchangeTraded2026-07-3116558472core:ShareCapital2026-07-3116558472core:SharePremium2026-07-3116558472core:RevaluationReserve2026-07-3116558472core:OtherReservesSubtotal2026-07-3116558472core:RetainedEarningsAccumulatedLosses2026-07-3116558472core:NetGoodwill2025-07-0216558472core:IntangibleAssetsOtherThanGoodwill2025-07-0216558472core:LandBuildings2025-07-0216558472core:PlantMachinery2025-07-0216558472core:Vehicles2025-07-0216558472core:FurnitureFittings2025-07-0216558472core:OfficeEquipment2025-07-0216558472core:AfterOneYear2025-07-0216558472core:WithinOneYear2025-07-0216558472core:ListedExchangeTraded2025-07-0216558472core:UnlistedNon-exchangeTraded2025-07-0216558472core:ShareCapital2025-07-0216558472core:SharePremium2025-07-0216558472core:RevaluationReserve2025-07-0216558472core:OtherReservesSubtotal2025-07-0216558472core:RetainedEarningsAccumulatedLosses2025-07-0216558472core:NetGoodwill2025-07-0116558472core:IntangibleAssetsOtherThanGoodwill2025-07-0116558472core:LandBuildings2025-07-0116558472core:PlantMachinery2025-07-0116558472core:Vehicles2025-07-0116558472core:FurnitureFittings2025-07-0116558472core:OfficeEquipment2025-07-0116558472core:AfterOneYear2025-07-0116558472core:WithinOneYear2025-07-0116558472core:ListedExchangeTraded2025-07-0116558472core:UnlistedNon-exchangeTraded2025-07-0116558472core:ShareCapital2025-07-0116558472core:SharePremium2025-07-0116558472core:RevaluationReserve2025-07-0116558472core:OtherReservesSubtotal2025-07-0116558472core:RetainedEarningsAccumulatedLosses2025-07-0116558472core:AfterOneYear2025-07-032026-07-3116558472core:WithinOneYear2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:CostValuation2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-07-032026-07-3116558472core:Non-currentFinancialInstrumentscore:CostValuation2026-07-3116558472core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-07-3116558472core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-07-3116558472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-07-3116558472core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-07-3116558472core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-07-3116558472core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-07-3116558472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-07-3116558472core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-07-3116558472core:Non-currentFinancialInstrumentscore:CostValuation2025-07-0216558472core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-07-0216558472core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-07-0216558472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-07-0216558472core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-07-0216558472core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-07-0216558472core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-07-0216558472core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-07-0216558472core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-07-0216558472bus:Director12025-07-032026-07-3116558472bus:Director22025-07-032026-07-3116558472bus:Director32025-07-032026-07-3116558472bus:Director42025-07-032026-07-3116558472bus:Director52025-07-032026-07-31

NOMAD NEUROSCIENCE LTD

Registered Number
16558472
(England and Wales)

Unaudited Financial Statements for the Period ended
31 July 2026

NOMAD NEUROSCIENCE LTD
Company Information
for the period from 3 July 2025 to 31 July 2026

Directors

BLACK, Benjamin Shields
CASE, Oliver Harold Kenneth
DENARI, Santiago
SHINGLETON-SMITH, Callum Hawkins
WINTER, Guy Quentin, Dr

Company Secretary

DENARI, Santiago

Registered Address

10 Stevens Lane
Claygate
Esher
KT10 0TE

Registered Number

16558472 (England and Wales)
NOMAD NEUROSCIENCE LTD
Balance Sheet as at
31 July 2026

Notes

2026

£

£

Current assets
Debtors10,879
Cash at bank and on hand197,332
208,211
Creditors amounts falling due within one year3(15,694)
Net current assets (liabilities)192,517
Total assets less current liabilities192,517
Net assets192,517
Capital and reserves
Called up share capital1,095
Share premium237,405
Profit and loss account(45,983)
Shareholders' funds192,517
The financial statements were approved and authorised for issue by the Board of Directors on 1 October 2026, and are signed on its behalf by:
DENARI, Santiago
Director
Registered Company No. 16558472
NOMAD NEUROSCIENCE LTD
Notes to the Financial Statements
for the period ended 31 July 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

2026
Average number of employees during the year2
3.Creditors: amounts due within one year

2026

£
Trade creditors / trade payables11,480
Taxation and social security2,155
Other creditors2,059
Total15,694